The following funding news and opportunities were collected recently by Cancer Center Pre-Award Services and published in Cancer Center Update, a weekly e-newsletter for members and staff.

Visit the Research Funding Resources page for links to resources you can use to search for funding as well as University resources essential to application processes.

December 25

Cancer Center Update was not published because of holiday.

December 18

International Clinical Research Fellows Program (ICRF)
Fogarty International Center/NCI
Deadline: December 31, 2007, 4 p.m. EST
Funding: $45,000/yr stipend plus miscellaneous fees
The ICRF Program supports one year of mentored clinical research in a developing country setting for U.S. citizens or permanent residents in either post-residency clinical fellowships or in other health-related postdoctoral programs in oncology, including radiation therapy, physiology, heart, lung, and blood research and other cancer-related issues. It is sponsored by the Fogarty International Center and several collaborating institutes and centers at the National Institutes of Health and managed by Vanderbilt University, with fiscal support from the Office of AIDS Research, National Cancer Institute, and the National Heart, Lung, and Blood Institute.

December 11

Clinical Investigator Development Program
Center for Cancer Research, National Cancer Institute
Deadline: January 15, 2008
The Center for Cancer Research (CCR) announces a new training opportunity for physicians interested in dedicating their careers to clinical oncology research. The Clinical Investigator Development Program will link eligible clinicians to a vibrant, multidisciplinary research community of more than 250 talented CCR intramural scientists conducting cutting-edge research on the campuses of the National Institutes of Health in Bethesda and Frederick, Maryland. The CCR is nationally recognized as a premier training ground for clinical research, which is conducted in the state-of-the-art Clinical Research Center. The program goal is to assist board-eligible/board-certified translational researchers to transition from a mentored position to independent investigator in either laboratory-based or patient-oriented research so that they will be highly competitive for tenure-track appointments in academia or comparable positions in government and industry. Potential areas of interest include medical oncology, pediatric hematology-oncology, radiation oncology, surgical oncology, surgical pathology or related specialties.

Successful applicants will be awarded a 3-year appointment; competitive salary; dedicated laboratory space and budget; a full-time research support person; travel and training funds; access to an extensive infrastructure including research nursing, data-management support, animal facilities, core services and advanced technologies such as imaging/microscopy, protein chemistry and purification, mass spectrometry, flow cytometry, genomics and transgenics and knockout mice. An attractive federal government employee benefit package includes health, life and disability coverage, and a retirement savings program. Student loan repayment is possible through the NIH.

Research Grant Program
Brain Tumor Society
Deadline: January 16, 2008
Funding: up to $200,000 for 2 years
The Brain Tumor Society seeks letters of intent for scientific research on brain tumors directed at finding a cure. Any project with the potential to advance basic scientific and translational brain tumor research will be considered. Clinical projects will not be funded. Funds may be used for startup projects or supplementary funding.

Animal Model Development
Multiple Myeloma Research Foundation
Deadline: Senior Research Awards-February 1, 2008; Fellows’ Awards - March 1, 2008
Funding: up to $200,000/year for 2 years
Animal models are an important research tool for validating potential therapeutics for myeloma. However, today there are few available multiple myeloma mouse model systems for these critical studies. The Multiple Myeloma Research Foundation's Animal Model Development Award supports the development of a disease-representative mouse model.

Exfoliated Cells, Bioactive Food Components, and Cancer
(PA-08-030)-R01
(PA-08-031)-R21
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: For R01, varies with modular budget rules applied. For R21, $275,000 over 2 years, no more than $250,000 in one year.
The National Cancer Institute invites applications for new R01 grants focusing on research to critically evaluate the use of exfoliated cells to monitor the physiological effects of dietary bioactive food components thought to be involved with cancer prevention.

Molecular Approaches to Diet and Pancreatic Cancer Prevention (R01)
(PA-08-032)
National Cancer Institute
Application Receipt Date(s): Multiple dates, See announcement.
Funding: Varies with modular budget rules applied. (Generally $250,000/year for up to 5 years)
This Funding Opportunity Announcement encourages grant applications that propose innovative preclinical and clinical studies to determine how dietary energy intake and bioactive food components, including alcohol, influence pancreatic cancer development and prevention. 

Thyroid in Aging
(PA-08-037)—R01
(PA-08-038)—R21
(PA-08-039)—R03
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: For R01, varies with modular budget rules applied. For R21, $275,000 over 2 years, no more than $250,000 in one year. For R03, up to $100,000 over 2 years in $25,000 modules, with no more than $50,000/year.
The purpose of this funding opportunity announcement (FOA) is to encourage submission of investigator-initiated research applications on the thyroid in aging. This FOA is intended to promote basic, translational, and clinical studies leading to increased understanding of the physiology of the aging thyroid and improved diagnosis and management of thyroid disease in the elderly.

December 4

No listings were published.